Current Report Filing (8-k)
November 20 2018 - 12:35PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 7, 2018
Date of Report (Date of earliest event reported)
WEARABLE
HEALTH SOLUTIONS, INC.
(Exact name of registrant as specified in
its charter)
|
Nevada
|
|
333-153290
|
|
26-3534190
|
|
(State or other jurisdiction of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
3960 Howard Hughes Pkwy, Suite 500
Las Vegas, NV
|
|
89196
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code
702-990-3590
(Former name or former address, if
changed since last report)
200 West Church
Road, Suite B
King
of Prussia, PA 19406
Check the appropriate box below if the Form
8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
¨
ITEM 5.01 CHANGES IN CONTROL OF REGISTRANT
On October 26, 2018, a change in control
of Wearable Health Solutions, Inc. (the "Company") occurred by virtue of the Company's largest shareholder Mina Mar Group
selling 4,000,000 shares of the Company's Preferred Series E stock to the Purchasing Shareholder (Exhibit 99.1). Such shares represent
58% of the Company's total issued and outstanding shares of common stock. As part of the sale of the shares, the Majority Shareholders
arranged with Daniel Sobolowski, prior to resigning as the sole member of the Company's Board of Directors and to appoint new officers
and directors of the Company (see Item 5.02 below).
ITEM 5.02 DEPARTURE OF DIRECTORS OR
PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS
Effective October 30, 2018, the Company
accepted the resignation of Daniel Sobolowski as the officer of the Company and as a member of the Company’s board of directors.
The resignation of Mr. Sobolowski was not due to any disagreement with the Company on any
matter relating to its operations, policies or practices. Simultaneously, Mr. Charles Langrill, was elected as the Company’s
Chairman, CEO and Director.
ITEM 8.01 - Other Events
The Company has a new corporate address located at 3960 Howard
Hughes Pkwy, Suite 500, Las Vegas, NV 89169.
ITEM 9.01. FINANCIAL STATEMENTS AND
EXHIBITS.
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
WEARABLE HEALTH SOLUTIONS, INC.
DATE: November 20, 2018
By:
/s/ Charles Langrill
Name: Charles Langrill
Title: CEO
Wearable Health Solutions (PK) (USOTC:WHSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Wearable Health Solutions (PK) (USOTC:WHSI)
Historical Stock Chart
From Apr 2023 to Apr 2024
